Universiti Putra Malaysia (UPM) and Zahran Megaclinic Group
(KMZ) signed a Memorandum of Understanding (MoU) which is 
an "Advance" Health Screening Screening Package for Malaysians
including blood tests and diagnostic tests such as MRI/MRA,
CT Scan, ultrasound test, genetic screening test etc. on 
20 April 2022 at the Serdang Briefing Hall, UPM.

The MoU was signed by the Vice Chancellor of UPM, 
the Honorable Prof. Dato ’Dr. Mohd Roslan Sulaiman together 
with Zahran Megaclinic Group Chief Executive Officer,
Dato 'Mohd Nafidz Hj. Abdul Razak and witnessed by the 
Deputy Vice Chancellor (Industry and Community Network), 
UPM, Prof. Ir. Dr. B.T. Hang Tuah Baharudin and General
Manager of Zahran Megaclinic Group, Dr. Sazarul Zafirah
Dato ’Seri Zainal Abidin.

Also present, the Director of the UPM Nuclear Diagnostic 
Imaging Center, Prof. Prof. Dr. Fathinul Fikri Ahmad Saad, 
Dean of the Faculty of Medicine and Health Sciences (FPSK),
UPM, Prof. Dr. Zamberi Sekawi, and the management of Zahran
Megaclinic Group (KMZ).

UPM Vice Chancellor, The Honorable Prof. Dr. Mohd Roslan 
Sulaiman said the cooperation was in line with the UPM 
Strategic Plan 2021-2025, Goal 3, which is to Preserve
the Industry and Community Network Ecosystem.

Zahran Megaclinic Group Executive Officer, Dato ’Mohd
Nafidz Hj. Abdul Razak said through the cooperation, both
parties would always work together in providing health
screening services to Malaysians in particular, quickly and
without having to wait long while providing services at
affordable.

Date of Input: 21/04/2022 | Updated: 21/04/2022 | faidhi